Improved insulin sensitivity after treatment with PPAR&ggr; and PPAR&agr; ligands is mediated by genetically modulated transcripts

No abstract is available for this paper.

• Publication year

  2012

• Venue

  Pharmacogenetics & Genomics

• Publication date

  2012-07-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1097/FPC.0b013e328352a72ePMID 22437669PMCID PMC3376224
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Antidiabetic actions of a non–agonist PPARγ ligand blocking Cdk5–mediated phosphorylation

  2012cited by this paper
• Integrative genomics strategies to elucidate the complexity of drug response.

  2011cited by this paper
• Type 2 Diabetes Can Be Prevented With Early Pharmacological Intervention

  2011cited by this paper
• Platelet CD36 surface expression levels affect functional responses to oxidized LDL and are associated with inheritance of specific genetic polymorphisms.

  2011cited by this paper
• The Architecture of Gene Regulatory Variation across Multiple Human Tissues: The MuTHER Study

  2011cited by this paper
• Pharmacogenetics in type 2 diabetes: potential implications for clinical practice

  2011cited by this paper
• Synergistic improvement in insulin resistance with a combination of fenofibrate and rosiglitazone in obese type 2 diabetic mice

  2011cited by this paper
• Metabolite profiles and the risk of developing diabetes

  2011cited by this paper
• Anti-Diabetic Actions of a Non-Agonist PPARγ Ligand Blocking Cdk5-Mediated Phosphorylation

  2011cited by this paper
• Pioglitazone for diabetes prevention in impaired glucose tolerance.

  2011cited by this paper
• Global Gene Expression Profiles of Subcutaneous Adipose and Muscle From Glucose-Tolerant, Insulin-Sensitive, and Insulin-Resistant Individuals Matched for BMI

  2011cited by this paper
• An integrative genomics approach identifies activation of thioredoxin/thioredoxin reductase-1-mediated oxidative stress defense pathway and inhibition of angiogenesis in obese nondiabetic human subjects.

  2011cited by this paper
• Branching out for detection of type 2 diabetes.

  2011cited by this paper
• The macrophage Ox-LDL receptor, CD36 and its association with type II diabetes mellitus.

  2011cited by this paper
• Decreased AMP-activated protein kinase activity is associated with increased inflammation in visceral adipose tissue and with whole-body insulin resistance in morbidly obese humans.

  2011cited by this paper
• Zinc-α2-glycoprotein: an adipokine modulator of body fat mass?

  2010cited by this paper
• Peroxisome proliferator-activated receptor gamma (PPARγ): Is the genomic activity the only answer?

  2010cited by this paper
• New genetic loci implicated in fasting glucose homeostasis and their impact on type 2 diabetes risk

  2010cited by this paper
• Genetic variation in GIPR influences the glucose and insulin responses to an oral glucose challenge

  2010cited by this paper
• Mechanisms of human insulin resistance and thiazolidinedione-mediated insulin sensitization

  2009cited by this paper
• Pioglitazone stimulates AMP-activated protein kinase signalling and increases the expression of genes involved in adiponectin signalling, mitochondrial function and fat oxidation in human skeletal muscle in vivo: a randomised trial

  2009cited by this paper
• Modulated Modularity Clustering as an Exploratory Tool for Functional Genomic Inference

  2009cited by this paper
• Validation of Candidate Causal Genes for Abdominal Obesity Which Affect Shared Metabolic Pathways and Networks

  2009cited by this paper
• PPARγ activation in adipocytes is sufficient for systemic insulin sensitization

  2009cited by this paper
• Therapeutic Potential of Peroxisome Proliferators–Activated Receptor-α/γ Dual Agonist With Alleviation of Endoplasmic Reticulum Stress for the Treatment of Diabetes

  2008cited by this paper
• Adipocyte dysfunctions linking obesity to insulin resistance and type 2 diabetes

  2008cited by this paper
• Fat and beyond: the diverse biology of PPARgamma.

  2008cited by this paper
• Therapeutic potential of peroxisome proliferators--activated receptor-alpha/gamma dual agonist with alleviation of endoplasmic reticulum stress for the treatment of diabetes.

  2008cited by this paper
• Activation of AMP‐activated protein kinase, inhibition of pyruvate dehydrogenase activity, and redistribution of substrate partitioning mediate the acute insulin‐sensitizing effects of troglitazone in skeletal muscle cells

  2008cited by this paper
• Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources

  2008cited by this paper
• Impaired Fasting Glucose and Impaired Glucose Tolerance

  2007cited by this paper
• Effect of pioglitazone on atherogenic outcomes in type 2 diabetic patients: a comparison of responders and non-responders.

  2007cited by this paper
• GeneTrail—advanced gene set enrichment analysis

  2007cited by this paper
• Thiazolidinediones enhance skeletal muscle triacylglycerol synthesis while protecting against fatty acid-induced inflammation and insulin resistance.

  2007cited by this paper
• Functions of AMP‐activated protein kinase in adipose tissue

  2006cited by this paper
• Thiazolidinediones can rapidly activate AMP-activated protein kinase in mammalian tissues.

  2006cited by this paper
• Expression of CD68 and macrophage chemoattractant protein-1 genes in human adipose and muscle tissues: association with cytokine expression, insulin resistance, and reduction by pioglitazone.

  2005cited by this paper
• PermutMatrix: a graphical environment to arrange gene expression profiles in optimal linear order

  2005cited by this paper
• Pioglitazone improves insulin sensitivity through reduction in muscle lipid and redistribution of lipid into adipose tissue.

  2005cited by this paper
• Pioglitazone treatment activates AMP-activated protein kinase in rat liver and adipose tissue in vivo.

  2004cited by this paper
• Thiazolidinediones.

  2004cited by this paper
• Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin.

  2002cited by this paper
• Adipocyte-Derived Plasma Protein, Adiponectin, Suppresses Lipid Accumulation and Class A Scavenger Receptor Expression in Human Monocyte-Derived Macrophages

  2001cited by this paper
• In silico prediction of protein-protein interactions in human macrophages

  2001cited by this paper
• Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance.

  2001cited by this paper
• The PPARs: from orphan receptors to drug discovery.

  2000cited by this paper
• Bioinformatics Applications Note Genetics and Population Analysis Genevar: a Database and Java Application for the Analysis and Visualization of Snp-gene Associations in Eqtl Studies

  year unknowncited by this paper

• The pan-PPAR agonist lanifibranor improves cardiometabolic health in patients with metabolic dysfunction-associated steatohepatitis

  2024cites this paper
• Brown fat thermogenesis and branched-chain amino acids in metabolic disease.

  2023cites this paper
• Whole-body insulin resistance and energy expenditure indices, serum lipids, and skeletal muscle metabolome in a state of lipoprotein lipase overexpression

  2021cites this paper
• Rosiglitazone remodels the lipid droplet and britens human visceral and subcutaneous adipocytes ex vivo[S]

  2019cites this paper
• Mitochondrial Dysfunction and Diabetes: Is Mitochondrial Transfer a Friend or Foe?

  2019cites this paper
• Diabetes pharmacotherapy and effects on the musculoskeletal system

  2018cites this paper
• The effects of flavonoid compound from Agrimonia pilosa Ledeb on promotting 3T3-L1 preadipocytes differentiation by activating PPARγ partially

  2017cites this paper
• New insight into determining indicators of metabolic status in women: Expression of PPARγ and FABP4 in PBMCs

  2017cites this paper
• Lipid oxidation products in the pathogenesis of non-alcoholic steatohepatitis.

  2017cites this paper
• Does Thiazolidinedione therapy exacerbate fluid retention in congestive heart failure?

  2016cites this paper
• Branched-chain amino acids as biomarkers in diabetes.

  2016cites this paper
• A Metabolic Inhibitory Cocktail for Grave Cancers: Metformin, Pioglitazone and Lithium Combination in Treatment of Pancreatic Cancer and Glioblastoma Multiforme

  2016influential citation
• Modulation of PPAR Expression and Activity in Response to Polyphenolic Compounds in High Fat Diets

  2016cites this paper
• AMP-Activated Protein Kinase Mediates the Antiplatelet Effects of the Thiazolidinediones Rosiglitazone and Pioglitazone

  2016cites this paper
• Metabolic Inflexibility with Obesity and the Effects of Fenofibrate on Skeletal Muscle Fatty Acid Oxidation

  2016cites this paper
• Effects of pioglitazone on cardiac and adipose tissue pathology in rats with metabolic syndrome.

  2015cites this paper
• Obesity Associated Modulation of miRNA and Co-Regulated Target Transcripts in Human Adipose Tissue of Non-Diabetic Subjects

  2015cites this paper
• Pioglitazone Treatment Reduces Adipose Tissue Inflammation through Reduction of Mast Cell and Macrophage Number and by Improving Vascularity

  2014cites this paper
• Mitochondria: a possible nexus for the regulation of energy homeostasis by the endocannabinoid system?

  2014cites this paper
• Molecular and metabolic profiles suggest that increased lipid catabolism in adipose tissue contributes to leanness in domestic chickens.

  2014cites this paper
• Expression quantitative trait analyses to identify causal genetic variants for type 2 diabetes susceptibility.

  2014cites this paper
• Phytoestrogens and the metabolic syndrome.

  2014cites this paper
• Inverse Regulation of In fl ammation and Mitochondrial Function in Adipose Tissue De fi nes Extreme Insulin Sensitivity in Morbidly Obese Patients

  2013cites this paper
• Free radical biology for medicine: learning from nonalcoholic fatty liver disease.

  2013cites this paper
• Inverse Regulation of Inflammation and Mitochondrial Function in Adipose Tissue Defines Extreme Insulin Sensitivity in Morbidly Obese Patients

  2013cites this paper
• Intermittent Claudication: New Targets for Drug Development

  2013cites this paper
• Pioglitazone Treatment Reduces Adipose Tissue Inflammation Pioglitazone Treatment Reduces Adipose Tissue Inflammation Through Reduction of Mast Cell and Macrophage Number and by Through Reduction of Mast Cell and Macrophage Number and by Improving Vascularity Improving Vascularity

  year unknowninfluential citation